Art
J-GLOBAL ID：200902016359911438   Reference number：92A0394163

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

Author (9)：
PECK C C

About PECK C C

(U.S. Food and Drug Administration, Rockville)

About U.S. Food and Drug Administration, Rockville

, 
BARR W H

About BARR W H

(Virginia Commonwealth Univ., Richmond)

About Virginia Commonwealth Univ., Richmond

, 
BENET L Z

About BENET L Z

(Univ. California, San Francisco)

About Univ. California, San Francisco

, 
FURST D E

About FURST D E

(Ciba-Geigy Pharmaceuticals, Summit)

About Ciba-Geigy Pharmaceuticals, Summit

, 
LEVY G

About LEVY G

(State Univ. New York at Buffalo, Amherst)

About State Univ. New York at Buffalo, Amherst

, 
RODMAN J H

About RODMAN J H

(St. Jude Children’s Research Hospital, Memphis)

About St. Jude Children’s Research Hospital, Memphis

, 
SCHENTAG J J

About SCHENTAG J J

(Millard Fillmore Hospital, Buffalo)

About Millard Fillmore Hospital, Buffalo

, 
SHEINER L B

About SHEINER L B

(Univ. California Medical Center, San Francisco)

About Univ. California Medical Center, San Francisco

, 
YACOBI A

About YACOBI A

(American Cyanamid Co., Pearl River)

About American Cyanamid Co., Pearl River


Material：
Clinical Pharmacology & Therapeutics  (Clin Pharmacol Ther)

About Clinical Pharmacology & Therapeutics


Volume： 51  Issue： 4  Page： 465-473  Publication year： Apr. 1992 
JST Material Number： A0721B  ISSN： 0009-9236  Document type： Article
Country of issue： United States (USA)  Language： ENGLISH (EN)

Return to Previous Page

TOP

BOTTOM